Login
Clearbridge
CLEARBRIDGE HEALTH LIMITED
Quotes 10 Minutes Delayed. Updated at 26 Nov 2021 17:13
| Last (SGD): 0.117 | Change: +0.008 | High: 0.119 | Remarks: - |
| Change (%): +7.34 | Low: 0.108 |
Loading search items...
Mode - Streaming
Switch to Static Mode?
Price Highlight
Index Highlight
STI
3,166.3
-55.2 (-1.72%)
-
STI Straits Times Index
3,166.3-55.2 (-1.72%) -
KLCI FTSE Bursa Malaysia KLCI
1,512.2-5.4 (-0.35%)Index delayed 15 minutes -
HSI Hang Seng Index
24,080.5-659.6 (-2.67%)Index delayed 15 minutes -
SSE SSE Composite Index
3,564.1-20.1 (-0.56%)Index delayed 15 minutes -
N225 Nikkei 225
28,751.6-747.7 (-2.53%)Index delayed 20 minutes -
JCI Jakarta Composite Index
6,561.6-137.8 (-2.06%)Index delayed 10 minutes
- Volume: 1,737.0M
- Value: 1,744.7M
- Rise: 72
- Fall: 305
- Unch: 381
Intraday Market Ticker Help
| Time | Name | Type | Price | Vol |
|---|
-
Top Active
-
Top Gainer
-
Top Loser
| Name | Last | Change |
|---|---|---|
| 0.021 | -0.004 | |
| 0.084 | -0.001 | |
| 0.400 | +0.110 | |
| 0.795 | -0.035 | |
| 0.695 | -0.020 | |
| 0.006 | -0.002 | |
| 2.440 | -0.030 | |
| 0.022 | +0.001 | |
| 1.550 | -0.020 | |
| 0.061 | - |
World Indices
| Name | Last | Change |
|---|---|---|
| Nasdaq | 15,491.7 | -353.6 |
| HSI | 24,080.5 | -659.6 |
| HSCEI | 8,576.1 | -233.7 |
| Jakarta | 6,561.6 | -137.8 |
| Nikkei 225 | 28,751.6 | -747.7 |
| SSE Comp | 3,564.1 | -20.1 |
| Shanghai A | 3,735.3 | -21.1 |
| Shanghai B | 281.0 | -1.2 |
| KOSPI | 2,936.4 | -43.8 |
Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.
Fundamental - Factsheet
Help-
Factsheet
Free TrialCompany Background
Clearbridge Health Limited is a healthcare company with a focus on the delivery of precision medicine in Asia. The Group’s vision is to empower clinicians and healthcare professionals to make more reliable and accurate diagnoses, provide insights to disease management and tailor personalised prevention and timely treatment programmes for patients. The Group’s technology agnostic approach allows it to adopt the most appropriate technology in each segment of its business and the products and/or services it offers.The Group’s business comprises (a) provision of laboratory testing services; (b) ownership and operation of medical clinics/centres; and (c) strategic equity participation in precision medical technology companies which complement its business objectives.
Key Statistics
| EPS (SGD) a | 0.00100 | Trailing EPS (SGD) b | -0.01769 | NAV (SGD) c | 0.0995 |
|---|---|---|---|---|---|
| PE a | 117.000 | Trailing PE d | - | Price / NAV c | 1.1759 |
| Dividend Yield (%) e | - | Cash In Hand (SGD) f | 0.0309 | Issued & Paid-up Shares g | 617,215,000 |
| Piotroski F Score | 8 | Market Cap (M) | 72.214 | Free Float (%) | 54.6 |
| Return on Equity (ROE) (%) h | n.m. | Revenue Growth (%) TTM i | -14.179 | ||
| Net Earnings Growth (%) j | -82.207 | Net Debt/Equity k | Net Cash | ||
| Under CPF Investment Scheme (CPFIS) | No | ||||
| Sector & Industry | Health and Social Services - Medical/Nursing Services | ||||
| Index Components | FTSE ST Catalist Index | ||||
Notes:
-
Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
-
Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
-
Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
-
Based on latest Full Year results announcement, adjusted for the current number of shares.
-
Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
-
Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
-
Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 19 Aug 2021. Please click here for more information.
-
Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
-
Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
-
Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
-
Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)
Latest News
-
19 Nov 2021 18:03
-
05 Nov 2021 18:10Clearbridge: Extraordinary/ Special General Meeting Source: SGXNet
-
05 Nov 2021 08:30
-
21 Oct 2021 19:22Clearbridge: Extraordinary/ Special General Meeting Source: SGXNet
-
15 Oct 2021 20:33
-
30 Sep 2021 08:34
-
24 Sep 2021 09:00Clearbridge Health receives second batch of Sinopharm Covid-19 vaccines in Singapore Source: Business Times
-
22 Sep 2021 09:35Clearbridge: Second Batch Of The Sinopharm COVID-19 Vaccine Arrives In Singapore. Source: ShareInvestor Express
Total Shareholder Return
| Period | Dividend Received | Capital Appreciation | Total Shareholder Return | |||
|---|---|---|---|---|---|---|
| Short Term Return | 5 Days | - | +0.005 | +4.46 % | ||
| 10 Days | - | +0.002 | +1.74 % | |||
| 20 Days | - | - | - | |||
| Medium Term Return | 3 Months | - | -0.003 | -2.50 % | ||
| 6 Months | - | -0.033 | -22.00 % | |||
| 1 Year | - | -0.045 | -27.78 % | |||
| Long Term Return | 2 Years | - | -0.021 | -15.22 % | ||
| 3 Years | - | -0.074 | -38.74 % | |||
| Annualised Return | Annualised | - | - | -15.07 % | ||
Notes:
-
Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
-
Script dividends are ignored in this calculation.
Peer Comparison
Notes:
-
For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
-
Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
-
Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
-
Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
-
For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
-
Industry/Index/Peers data is updated daily.
-
Peers are sorted by market capitalisation and only details for the top 10 will be shown.
More Information Available
More information is available to our subscribers, including:
- Consensus Estimates
- Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
- Insider Buying and Selling Report
If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.
Disclaimer:
While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-
- no liability is accepted for any errors or inaccuracies resulting from your use of these features;
- many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.